Currently, inadequate gaps in the care of stroke in LMICs include longer waiting times in the emergency department, a paucity of equipped stroke-dedicated units, funding deficiencies/financial difficulties in purchasing potentially lifesaving trans plasminogen activator (tPA), and under-established secondary prevention public health promotion strategies [25]. This evidence concerns the gene PLAT and stroke disorder.